Three categories that should not be merged
In Spain, personal cannabis use, membership of an association and treatment with a cannabis-based medicine belong to different legal questions. None is a substitute for the others. An individual’s private conduct does not create a public retail permission, and an association’s statutes do not operate as a medical prescription.
The distinction is useful because the same plant can appear in all three conversations while the relevant institutions change. Public-security law, criminal law, association law and medicines regulation each address particular activities.
Private conduct has limits outside the home
Personal consumption in a genuinely private setting is not itself criminalised in the same manner as trafficking. Public consumption or possession is different: Article 36.16 of Organic Law 4/2015 covers unlawful use or possession in public places, roads, public establishments and collective transport, even without trafficking intent.
That means the legal question can change when a person moves between settings. A private destination does not make the journey private. It also explains why a general description of Spain as tolerant cannot replace the specific distinction between private behaviour and public possession.
Association identity does not decide supply legality
Organic Law 1/2002 governs matters such as statutes, governing bodies, accounts and member rights. A cannabis association can therefore have an institutional identity under association law while its actual activities remain subject to other legislation.
Article 368 of the Criminal Code addresses trafficking and conduct promoting or facilitating unlawful consumption. Nonprofit status does not by itself remove that provision. The legal significance lies in the facts of the activity rather than simply the existence of a card, a member register or a closed door.
Medical preparations have a separate chain of responsibility
Royal Decree 903/2025 created the framework for standardised cannabis preparations used in standardised magistral formulations. AEMPS manages the preparation register; specialist physicians prescribe within the framework; hospital pharmacy services prepare and dispense the formulations and participate in follow-up.
This chain links composition, clinical justification and professional responsibility. The 2026 National Formulary monograph is already published. The system therefore should not be described as waiting for its first monograph, nor confused with the activity of a social association.
The distinction explains the practical landscape
A registered preparation is an input to a regulated medical process, not an ordinary consumer cannabis brand approved for every purpose. Likewise, an association’s legal existence concerns its organisation, not a general authorisation of every act by its members.
These differences explain Spain’s landscape more accurately than a single promise of access. The relevant question is always which activity is being described and which institution governs it: private personal conduct, a collective organisation or a clinical treatment process. Keeping those categories separate prevents a fact that is true in one setting from being stretched into permission in another.
Sources & further reading
General information, not individual legal or medical advice.